FR 2025-03903

The document under review is a notice from the Federal Register, indicating an amendment to a previously announced meeting organized by the National Institutes of Health (NIH). The meeting in question is for the Oncology 2—Translational Clinical Integrated Review Group focusing on molecular cancer diagnosis and classification.

General Summary

The notice informs the public that there has been a change regarding the contact details for the Scientific Review Officer handling this specific NIH meeting. Formerly, Lawrence Ka-Yun Ng was the point of contact, but this has been updated to Victor Panchenko, Ph.D. The meeting itself, scheduled to take place from May 1 to May 2, 2025, remains unchanged concerning date and location, set to occur in Bethesda, Maryland. It is important to note that this meeting is closed to the public, meaning that it is not open for general attendance or observation.

Significant Issues or Concerns

Upon reviewing the notice, it becomes apparent that the language used is straightforward, ensuring clarity for readers with a general knowledge background. There are no technical terms or acronyms that might confuse the public, thus making the notice accessible. Moreover, the notice does not delve into financials or show evidence of potential bias, as it strictly states procedural changes.

Impact on the Public Broadly

For the general public, this document has minimal direct impact, given that the meeting is closed and pertains to a specific field within medical research. In broader terms, such meetings are part of a process that could lead to advancements in cancer diagnostics and therapy. Consequently, while the immediate public interest might be limited, the long-term benefits of reviews and discussions in such meetings can contribute significantly to healthcare improvements and the fight against cancer.

Impact on Specific Stakeholders

Specific stakeholders, including researchers, healthcare professionals, and institutions focused on cancer research, may find this change in contact pertinent. For these parties, knowing the updated contact information allows them to reach out for necessary collaboration or inquiries around the review group's activities.

In conclusion, while this document primarily serves an administrative function and holds minimal immediate public consequence, its relevance to scientific and medical communities reinforces the importance of maintaining accurate and transparent communication protocols within federal agencies. Such diligence aids in fostering progress in crucial areas like cancer research, ultimately benefiting society as a whole over time.